The 15 most promising drug companies

Want a peek at the future of the industry? Our sister publication FierceBiotech has released its pick of the top 15 companies at the forefront of drug development. We here at FiercePharma don't usually cover the development side of things, but its worth taking a look to see which companies are on the cutting edge of the field. Biotech is a risky game and while not all of these companies will be as successful as they hope to be, you can bet at least a few on the list will make headlines as future acquisition targets or IPO-stage companies with commercial opportunities to pursue. Click here to see the 2008 Fierce 15 winners. List

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.